Elkhorn Partners’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $80.3K | Buy |
|
|||||
|
2025
Q2 | $107K | Buy |
|
|||||
|
2025
Q1 | $102K | Buy |
|
|||||
|
2024
Q4 | $139K | Sell |
|
|||||
|
2024
Q3 | $120K | Buy |
|
|||||
|
2024
Q2 | $91K | Buy |
|
|||||
|
2024
Q1 | $208K | Sell |
|
|||||
|
2023
Q4 | $97K | Buy |
|
|||||
|
2023
Q3 | $63K | Sell |
|
|||||
|
2023
Q2 | $69K | Buy |
|
|||||
|
2023
Q1 | $58K | Buy |
|
|||||
|
2022
Q4 | $41K | Buy |
|
|||||
|
2022
Q3 | $39K | Buy |
|
|||||
|
2022
Q2 | $52K | Buy |
|
|||||
|
2022
Q1 | $47K | Buy |
|
|||||
|
2021
Q4 | $104K | Buy |
|
|||||
|
2021
Q3 | $90K | Buy |
|
|||||
|
2021
Q2 | $40K | Buy |
|
|||||
|
2021
Q1 | $12K | Buy |
|
|||||
|
2020
Q4 | $15K | Sell |
|
|||||
|
2020
Q3 | $14K | Sell |
|
|||||
|
2020
Q2 | $38K | Sell |
|
|||||
|
2020
Q1 | $34K | Sell |
|
|||||
|
2019
Q4 | $46K | Hold |
|
|||||
|
2019
Q3 | $56K | Buy |
|
|||||
|
2019
Q2 | $50K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $46K | Hold |
|
|||||
|
2018
Q3 | $73K | Hold |
|
|||||
|
2018
Q2 | $69K | Buy |
|
|||||
|
2018
Q1 | $101K | Hold |
|
|||||
|
2017
Q4 | $89K | Hold |
|
|||||
|
2017
Q3 | $212K | Buy |
|
|||||
|
2017
Q2 | $229K | Hold |
|
|||||
|
2017
Q1 | $209K | Buy |
|
|||||
|
2016
Q4 | $249K | Buy |
|
|||||
|
2016
Q3 | $227K | Sell |
|
|||||
|
2016
Q2 | $253K | Sell |
|
|||||
|
2016
Q1 | $284K | Buy |
|
|||||
|
2015
Q4 | $251K | Buy |
|
|||||
|
2015
Q3 | $245K | Buy |
|